908 Devices Inc. (MASS)
NASDAQ • Healthcare
Last close at September 9, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, 908 Devices Inc. currently loses $74.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 9
in 60 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
About 908 Devices Inc.
908 Devices Inc. develops handheld analytical instruments for health and safety work, selling on-device mass spectrometry and infrared-based detection systems used to identify unknown substances, gases, vapors, and chemical hazards. The company trades on NASDAQ as MASS in the medical technology field, and generated $56.2 million of revenue in FY2025.
Today's Snapshot
MASS is trading 1.3% below yesterday's close, while its sector was flat. Canaccord, an investment bank, started covering 908 Devices with a buy rating.
Trading Volume
Below 10d avg (330.2K)
114.7K
vs S&P 500 Today
Underperforming Market
-0.78%
Updated: September 10, 2026 at 16:50 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$7.83 - $10.05Buy
- RSI (14)46.08Neutral
- Stochastic %K (14, 3, 3)6.18Buy
- MACD Level (12, 26)0.23Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.